Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide

por Chen, Nianhang, Zhou, Simon, Palmisano, Maria
Publicado 2016

Developing TeroENZ and TeroMAP modules for the terpenome research platform TeroKit

por Chen, Nianhang, Zhang, Rong, Zeng, Tao, Zhang, Xuting, Wu, Ruibo
Publicado 2023

Pharmacokinetics, metabolism and excretion of [(14)C]-lenalidomide following oral administration in healthy male subjects

por Chen, Nianhang, Wen, Lian, Lau, Henry, Surapaneni, Sekhar, Kumar, Gondi
Publicado 2011

Pharmacokinetics and pharmacodynamics of nab-paclitaxel in patients with solid tumors: Disposition kinetics and pharmacology distinct from solvent-based paclitaxel

por Chen, Nianhang, Li, Yan, Ye, Ying, Palmisano, Maria, Chopra, Rajesh, Zhou, Simon
Publicado 2014

Predicting lung adenocarcinoma disease progression using methylation-correlated blocks and ensemble machine learning classifiers

por Yu, Xin, Yang, Qian, Wang, Dong, Li, Zhaoyang, Chen, Nianhang, Kong, De-Xin
Publicado 2021

Aiding early clinical drug development by elucidation of the relationship between tumor growth inhibition and survival in relapsed/refractory multiple myeloma patients

por Cheng, Yiming, Hong, Kevin, Chen, Nianhang, Yu, Xin, Peluso, Teresa, Zhou, Simon, Li, Yan
Publicado 2022

Lenalidomide at Therapeutic and Supratherapeutic Doses Does Not Prolong QTc Intervals in the Thorough QTc Study Conducted in Healthy Men

por Chen, Nianhang, Ye, Ying, Liu, Liangang, Reyes, Josephine, Assaf, Mahmoud S, Kasserra, Claudia, Zhou, Simon, Palmisano, Maria
Publicado 2013

Novel C7-Substituted Coumarins as Selective Monoamine Oxidase Inhibitors: Discovery, Synthesis and Theoretical Simulation

por Wang, Dong, Hong, Ren-Yuan, Guo, Mengyao, Liu, Yi, Chen, Nianhang, Li, Xun, Kong, De-Xin
Publicado 2019

No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers

por Chen, Nianhang., Weiss, Daniel, Reyes, Josephine, Liu, Liangang, Kasserra, Claudia, Wang, Xiaomin, Zhou, Simon, Kumar, Gondi, Weiss, Lilia, Palmisano, Maria
Publicado 2014

Erratum to: No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunt...

por Chen, Nianhang, Weiss, Daniel, Reyes, Josephine, Liu, Liangang, Kasserra, Claudia, Wang, Xiaomin, Zhou, Simon, Kumar, Gondi, Weiss, Lilia, Palmisano, Maria
Publicado 2014

First‐in‐Human, Single‐ and Multiple‐Ascending‐Dose Studies in Healthy Subjects to Assess Pharmacokinetics, Pharmacodynamics, and Safety/Tolerability of Iberdomide, a Novel Cereblo...

por Ye, Ying, Gaudy, Allison, Schafer, Peter, Thomas, Michael, Weiss, Daniel, Chen, Nianhang, Liu, Liangang, Xue, Yongjun, Carayannopoulos, Leon, Palmisano, Maria
Publicado 2020

Species difference in paclitaxel disposition correlated with poor pharmacological efficacy translation from mice to humans

por Li, Ying Fei, Zhang, Chengyue, Zhou, Simon, He, Miao, Zhang, Huixia, Chen, Nianhang, Li, Feng, Luan, Xin, Pai, Manjunath, Yuan, Hebao, Sun, Duxin, Li, Yan
Publicado 2018

Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration

por Chen, Nianhang, Brachmann, Carrie, Liu, Xiping, Pierce, Daniel W., Dey, Joyoti, Kerwin, William S., Li, Yan, Zhou, Simon, Hou, Shihe, Carleton, Michael, Klinghoffer, Richard A., Palmisano, Maria, Chopra, Rajesh
Publicado 2015

Population Pharmacokinetics and Exposure–Response of Luspatercept, an Erythroid Maturation Agent, in Anemic Patients With Myelodysplastic Syndromes

por Chen, Nianhang, Kassir, Nastya, Laadem, Abderrahmane, Maxwell, Stephen E., Sriraman, Priya, Giuseppi, Ana Carolina, Ritland, Steve, Linde, Peter G., Budda, Balasubrahmanyam, Reynolds, Joseph G., Zhou, Simon, Palmisano, Maria
Publicado 2020

Population Pharmacokinetics and Exposure‐Response Relationship of Luspatercept, an Erythroid Maturation Agent, in Anemic Patients With β‐Thalassemia

por Chen, Nianhang, Kassir, Nastya, Laadem, Abderrahmane, Giuseppi, Ana Carolina, Shetty, Jeevan, Maxwell, Stephen E., Sriraman, Priya, Ritland, Steve, Linde, Peter G., Budda, Balasubrahmanyam, Reynolds, Joseph G., Zhou, Simon, Palmisano, Maria
Publicado 2020

A multicenter, open-label, phase 2 study of lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: the MM-021 trial

por Hou, Jian, Du, Xin, Jin, Jie, Cai, Zhen, Chen, Fangping, Zhou, Dao-bin, Yu, Li, Ke, Xiaoyan, Li, Xiao, Wu, Depei, Meng, Fanyi, Ai, Huisheng, Zhang, Jingshan, Wortman-Vayn, Honeylet, Chen, Nianhang, Mei, Jay, Wang, Jianmin
Publicado 2013